TIAA CREF Investment Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $1.02M | Buy |
127,307
+14,848
| +13% | +$119K | ﹤0.01% | 2310 |
|
2018
Q4 | $461K | Hold |
112,459
| – | – | ﹤0.01% | 2601 |
|
2018
Q3 | $630K | Sell |
112,459
-11,965
| -10% | -$67K | ﹤0.01% | 2623 |
|
2018
Q2 | $1.64M | Buy |
124,424
+1,958
| +2% | +$25.7K | ﹤0.01% | 2281 |
|
2018
Q1 | $1.74M | Sell |
122,466
-544
| -0.4% | -$7.73K | ﹤0.01% | 2175 |
|
2017
Q4 | $1.01M | Buy |
123,010
+372
| +0.3% | +$3.05K | ﹤0.01% | 2453 |
|
2017
Q3 | $1.45M | Sell |
122,638
-43,103
| -26% | -$511K | ﹤0.01% | 2331 |
|
2017
Q2 | $1.67M | Buy |
165,741
+65,426
| +65% | +$658K | ﹤0.01% | 2294 |
|
2017
Q1 | $1.17M | Sell |
100,315
-3,948
| -4% | -$46K | ﹤0.01% | 2432 |
|
2016
Q4 | $485K | Sell |
104,263
-10,835
| -9% | -$50.4K | ﹤0.01% | 2864 |
|
2016
Q3 | $891 | Sell |
115,098
-630
| -0.5% | -$5 | ﹤0.01% | 2598 |
|
2016
Q2 | $701K | Buy |
115,728
+2,788
| +2% | +$16.9K | ﹤0.01% | 2701 |
|
2016
Q1 | $962K | Hold |
112,940
| – | – | ﹤0.01% | 2496 |
|
2015
Q4 | $1.35M | Sell |
112,940
-4,855
| -4% | -$57.9K | ﹤0.01% | 2397 |
|
2015
Q3 | $1.19M | Hold |
117,795
| – | – | ﹤0.01% | 2465 |
|
2015
Q2 | $1.95M | Buy |
117,795
+30,855
| +35% | +$512K | ﹤0.01% | 2315 |
|
2015
Q1 | $1.35M | Buy |
86,940
+6,330
| +8% | +$98K | ﹤0.01% | 2468 |
|
2014
Q4 | $1.28M | Buy |
80,610
+1,131
| +1% | +$17.9K | ﹤0.01% | 2513 |
|
2014
Q3 | $848K | Sell |
79,479
-18,236
| -19% | -$195K | ﹤0.01% | 2734 |
|
2014
Q2 | $918K | Buy |
97,715
+21,475
| +28% | +$202K | ﹤0.01% | 2763 |
|
2014
Q1 | $526K | Buy |
76,240
+15,400
| +25% | +$106K | ﹤0.01% | 2922 |
|
2013
Q4 | $237K | Sell |
60,840
-4,091
| -6% | -$15.9K | ﹤0.01% | 3074 |
|
2013
Q3 | $330K | Sell |
64,931
-12,959
| -17% | -$65.9K | ﹤0.01% | 3018 |
|
2013
Q2 | $498K | Buy |
+77,890
| New | +$498K | ﹤0.01% | 2934 |
|